LEADER 02258nam  2200529 a 450 
001 9910461366703321
005 20200520144314.0
010   $a1-61668-824-6
035   $a(CKB)2670000000094430
035   $a(EBL)3020134
035   $a(SSID)ssj0000523982
035   $a(PQKBManifestationID)12162598
035   $a(PQKBTitleCode)TC0000523982
035   $a(PQKBWorkID)10545533
035   $a(PQKB)11041347
035   $a(MiAaPQ)EBC3020134
035   $a(Au-PeEL)EBL3020134
035   $a(CaPaEBR)ebr10675142
035   $a(OCoLC)923662902
035   $a(EXLCZ)992670000000094430
100   $a20100322d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aLupus nephritis$b[electronic resource] $efrontiers and challenges /$fHussein A. Sheashaa ... [et al.]
210   $aHauppauge, N.Y. $cNova Science Publishers$d2010
215   $a1 online resource (120 p.)
225 1 $aImmunology and immune system disorders
300   $aDescription based upon print version of record.
311   $a1-61668-367-8 
320   $aIncludes bibliographical references and index.
327   $aImmunopathogenesis of systemic lupus erythematosus nephritis -- Pathogenicity of autoantibodies -- BK virus and systemic lupus erythematosus -- Diagnosis of SLE -- Histological classification of lupus nephritis lesions -- Classification of lupus glomerulonephritis (LGN) -- Additional pathological features associated with SLE -- Lupus nephritis activity and chronicity indices -- Diagnosis and monitoring of renal disease -- End-stage renal disease and systemic lupus erythematosus -- Treatment of lupus nephritis -- Renal transplantation and SLE summary -- Lupus nephritis in children -- Outcome of LN in children -- Drug-induced lupus erythematosus and LN -- SLE and DILE.
410  0$aImmunology and immune system disorders.
606   $aLupus nephritis
608   $aElectronic books.
615  0$aLupus nephritis.
676   $a616.7/72
700   $aSheashaa$b Hussein A$0963375
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910461366703321
996   $aLupus nephritis$92184301
997   $aUNINA